Acadian Asset Management
MIST icon

Acadian Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

Acadian Asset Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,468
Closed -$24K – 2135
2026
Q1 		$24K Sell
20,468
-155,732
-88% -$273K ﹤0.01% 1934
2025
Q4 		$353K Buy
+176,200
New +$380K ﹤0.01% 1406
2022
Q3 		– Sell
-13,717
Closed -$84K – 1778
2022
Q2 		$84K Sell
13,717
-5,553
-29% -$34.1K ﹤0.01% 1392
2022
Q1 		$122K Buy
19,270
+6,889
+56% +$43.1K ﹤0.01% 1322
2021
Q4 		$79K Buy
12,381
+4,785
+63% +$28.7K ﹤0.01% 1418
2021
Q3 		$42K Sell
7,596
-4,473
-37% -$25.2K ﹤0.01% 1576
2021
Q2 		$67K Buy
+12,069
New +$68.5K ﹤0.01% 1747

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Acadian Asset Management's MIST Position: Q2 2026 in Review

Acadian Asset Management sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 20,468 shares — an estimated $24K sold.

Acadian Asset Management first reported a position in MIST in Q2 2021 and held it in 7 quarters. The position peaked at $353K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Acadian Asset Management reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 20,468 Milestone Pharmaceuticals shares in Q2 2026, an estimated $24K.
  • Acadian Asset Management first reported a position in Milestone Pharmaceuticals in Q2 2021 and held it in 7 quarters.
  • Acadian Asset Management's Milestone Pharmaceuticals position peaked at $353K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.